Amaurosis Fugax: Associations with Heritable Thrombophilia

Abstract

The aim of this study was to prospectively assess associations between amaurosis fugax, inherited thrombophilia, and acquired thrombophilia. Thrombophilia and hypofibrinolysis were studied in 11 cases (eight women, three men; all white) with amaurosis fugax, 57 ± 17 years old, selected by the absence of abnormal brain magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), magnetic resonance venography (MRV), ipsilateral internal carotid artery plaque, atrial fibrillation, or cardiac thrombus. Cases were compared to 78 healthy adult white controls (53 ± 18 years old) for serologic measures, and by polymerase chain reaction to 248 healthy white controls (78 adults, 170 children) for gene mutations. All 11 cases had one or more familial thrombophilic coagulation disorder including one heterozygous for the G1691A factor V Leiden mutation, two with low free protein S, four with high factor VIII, three with resistance to activated protein C, three homozygous for the C677T methylenetetrahydrofolate reductase (MTHFR) mutation, two compound C677T-A1298C MTHFR heterozygotes, and three with hypofibrinolytic 4G4G homozygosity for the PAI-1 gene. The case with factor VIII of 160% had two other thrombophilias (compound MTHFR C677T-A1298C heterozygosity, resistance to activated protein C), and hypofibrinolytic high Lp(a). Thrombophilic C677T MTHFR homozygosity or compound C677T-A1298C heterozygosity was present in five of 10 (50%) cases vs. 30 of 248 (12%) controls, Fisher’s p (p_f) = .005. Thrombophilic factor VIII was high in four of 10 (40%) cases vs. 0 of 38 controls, p_f = .001. Thrombophilic hyperestrogenemia in five of the eight women (four exogenous estrogen, one pregnant) may have interacted with inherited thrombophilia-hypofibrinolysis, promoting thrombus formation. In cases selected by the absence of abnormal brain magnetic resonance imaging, significant ipsilateral internal carotid artery plaque, atrial fibrillation, or cardiac thrombus, we speculate that amaurosis fugax can be caused by reversible (by anticoagulation) retinal artery thrombi associated with heritable thrombophilia and/or hypofibrinolysis, often augmented by estrogen-driven acquired thrombophilia.

Keywords

Amaurosis fugax Transient cerebral ischemic attack Inherited thrombophilia Inherited hypofibrinolysis Acquired thrombophilia Gene-environment interaction

References

Nguyen TN , Gans MS , Cote R. The prognosis of amaurosis fugas and hemispheric transient ischemic attacks. Can J Ophthalmol 1999;34:210.

Babikian V , Wijman CA , Koleini B , et al. Retinal ischemia and embolism. Etiologies and outcomes based on a prospective study. Cerebrovasc Dis 2001;12:108.

Lawrence PF , Oderich GS . Ophthalmologic findings as predictors of carotid artery disease. Vasc Endovasc Surg 2002;36:415.

Iwamoto T , Matsushima C , Shimizu S , et al. Carotid ultrasonographic and brain computerized tomographic findings in patients with vascular ocular syndromes. No To Shinkei 2002;54:119.

Donders RC . Dutch TMB Study Group . Clinical features of transient monocular blindness and the likelihood of atherosclerotic lesions of the internal carotid artery. J Neurol Neurosurg Psychiatry 2001;71:247.

Tegos TG , Sabetai MM , Nicolaides AN , et al. Patterns of cerebrovascular symptomatology associated with carotid atheroma. Eur J Neurol 2000;7:499.

Winterkorn J , Kupersmith MJ , Wirtschafter JD , et al. Treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med 1993;329:396.

Nesher G. Neurologic manifestations of giant cell arteritis. Clin Exp Rheumatol 2000;18:S24.

Vrethem M , Ernerudh J , Lindstrom F , et al. Cerebral ischemia associated with anticardiolipin antibodies. Acta Neurol Scand 1992;85:412.

10.

Pope JM , Canny CL , Bell DA . Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. Am J Med 1991;90:299.

11.

Petty GW , Brown RD Jr , Wisnant JP , et al. Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study. Ann Intern Med 1999;130:14.

12.

Glueck CJ , Wang P , Bell H , et al. Non-arteritic anterior ischemic optic neuropathy: Associations with homozygosity for the C677T methylenetetrahydrofolate reductase. J Lab Clin Med 2004;143:184.

13.

Glueck CJ , Bell H , Vadlamani L , et al. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol 1999;117:43.

14.

Rodeghiero F , Tosetto A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 1999;130:643.

15.

de Visser MC , Rosendaal FR , Bertina RM . A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood 1999;93:1271.

16.

Glueck CJ , Freiberg RA , Fontaine RN , et al. Hypofibrinolysis, Thrombophilia, Osteonecrosis. Clin Orthop 2001;386:19.

17.

Glueck CJ , Kupferminc MJ , Fontaine RN , et al. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001;97:44.

18.

Glueck CJ , Iyengar S , Goldenberg N , et al. Pseudotumor cerebri: Associations with coagulation disorders and polycystic ovary syndrome. J Lab Clin Med 2003;142:35.

19.

Balasa VV , Gruppo RA , Glueck CJ , et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and plasminogen activator inhibitor-1 levels in children and adults. Thromb Haemost 1999;81:739.

20.

Glueck CJ , Fontaine RN , Wang P. Interaction of heritable and estrogen-induced thrombophilia: Possible etiologies for ischemic optic neuropathy and ischemic stroke. Thromb Haemost 2001;85:256.

21.

Glueck CJ , Glueck HI , Tracy T , et al. Relationships between lipoprotein (a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism 1993;42:236.

22.

SAS Release 8. SAS Institute, SAS Circle, Box 8000, Cary NC 27512-8000.

23.

Zelterman D. Advanced log-linear models using SAS. 2002. SAS Institute Inc, Cary NC, 27512-8000.

24.

Palmowski AM , Ruprecht KW . Amaurosis fugax. Fortschr Med 1992;110:531.

25.

Derieux L , Gouomard JL , Catier A , et al. Fibrinolysis in the treatment of the amaurosis fugax: A case report. Fr Ophthalmol 2003;26:507.

26.

Bick RL , Alfar H , Goedecke C. Thrombophilic causes of retinal vascular thrombosis: Etiology and treatment outcomes. Clin Appl Thromb Hemost 2002;8:315.

27.

Goertler M , Blaser T , Krueger S , et al. Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke. J Neurol Neurosurg Psychiatry 2002;72:338.

28.

Eriksson SE . Enteric-coated acetylsalicylic acid plus dipyridamole compared to anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks. Acta Neurol Scand 1985;71:485.

29.

Olsson JE , Brechter C , Backlund H , et al. Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks. Stroke 1980:11:4.

30.

Greiner K , Peetz D , Winkgen A , et al. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 1999;23:155.

31.

Soria JM , Almasy L , Souto JC , et al. A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility. Blood 2003;101:163.

32.

Graf LL , Welsh CH , Qamar Z , et al. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden. Am J Clin Pathol 2003;119:52.

33.

Elishkewitch K , Berliner S , Eldor A , et al. High factor VIII as risk factor for venous thrombosis. Harefuah 2001;140:1122.

34.

Cakmak S , Derex L , Berruyer M , et al. Cerebral venous thrombosis: Clinical outcome and systematic screening of prothrombotic disorders. Neurology 2003;60:1175.

35.

Keijzer MB , den Heijer M , Blom HJ , et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002;88:723.

36.

Bleomenkamp KW , Helmerhorst FM , Rosendaal FR , et al. Thrombophilias and gynaecology. Best Pract Res Clin Obstet Gynaecol 2003;17:509.

37.

Szolnoki Z , Somogyvari F , Kondacs A , et al. Evaluation of the modifying effects of unfavorable genotypes on clinical risk factors for ischemic stroke. J Neurol Neurosurg Psychiatry. 2003;74:1615.

38.

Flegal KM , Carroll MD , Ogden CL , et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723.